Bone marrow status in patients with stage III-IV disease
| . | Stage III-IV . | |
|---|---|---|
| n . | (%) . | |
| Total | 54 | (100) |
| BM + | 31 | (58) |
| With multiple MALT locations | 8 | (15) |
| With one MALT location | 23 | (43) |
| BM − | 22 | (41) |
| With multiple MALT locations | 8 | (15) |
| With one MALT location | ||
| With multiple lymph node locations | 12 | (22) |
| With non-MALT liver location | 1 | (2) |
| With non-MALT pleura and spleen location | 1 | (2) |
| BM status unknown | ||
| With multiple MALT locations (lung + GI tract) | 1 | (1) |
| . | Stage III-IV . | |
|---|---|---|
| n . | (%) . | |
| Total | 54 | (100) |
| BM + | 31 | (58) |
| With multiple MALT locations | 8 | (15) |
| With one MALT location | 23 | (43) |
| BM − | 22 | (41) |
| With multiple MALT locations | 8 | (15) |
| With one MALT location | ||
| With multiple lymph node locations | 12 | (22) |
| With non-MALT liver location | 1 | (2) |
| With non-MALT pleura and spleen location | 1 | (2) |
| BM status unknown | ||
| With multiple MALT locations (lung + GI tract) | 1 | (1) |
BM+ indicates bone marrow involvement; BM− indicates no bone marrow involvement.